2021 Q3 Form 10-K Financial Statement

#000143774921028230 Filed on December 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 2020 Q3
Revenue $8.630M $35.17M $10.15M
YoY Change -15.01% 1.19% 10.23%
Cost Of Revenue $2.686M $10.29M $2.880M
YoY Change -6.74% 6.85% 4.61%
Gross Profit $5.944M $24.87M $7.274M
YoY Change -18.28% -0.98% 12.58%
Gross Profit Margin 68.88% 70.73% 71.64%
Selling, General & Admin $4.719M $16.84M $5.000M
YoY Change -5.62% -6.86% 8.7%
% of Gross Profit 79.39% 67.7% 68.74%
Research & Development $1.871M $7.226M $1.703M
YoY Change 9.86% 14.64% -1.9%
% of Gross Profit 31.48% 29.05% 23.41%
Depreciation & Amortization $497.0K $1.263M $272.0K
YoY Change 82.72% 42.07% -24.23%
% of Gross Profit 8.36% 5.08% 3.74%
Operating Expenses $6.590M $24.07M $6.703M
YoY Change -1.69% -1.3% 5.79%
Operating Profit -$646.0K $807.0K $571.0K
YoY Change -213.13% 9.65% 356.8%
Interest Expense -$12.00K -$28.00K -$37.00K
YoY Change -67.57% -95.74% -84.58%
% of Operating Profit -3.47% -6.48%
Other Income/Expense, Net $22.00K $2.285M $41.00K
YoY Change -46.34% -397.91% -180.39%
Pretax Income -$636.0K $3.092M $575.0K
YoY Change -210.61% -10074.19% -446.39%
Income Tax -$178.0K $15.00K $136.0K
% Of Pretax Income 0.49% 23.65%
Net Earnings -$458.0K $3.077M $439.0K
YoY Change -204.33% -1818.99% -345.25%
Net Earnings / Revenue -5.31% 8.75% 4.32%
Basic Earnings Per Share $0.37
Diluted Earnings Per Share -$51.72K $0.36 $55.25K
COMMON SHARES
Basic Shares Outstanding 9.033M 8.230M 7.922M shares
Diluted Shares Outstanding 8.650M

Balance Sheet

Concept 2021 Q3 2021 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.28M $10.28M $7.894M
YoY Change 30.26% 30.26% 77.07%
Cash & Equivalents $9.989M $9.989M $7.619M
Short-Term Investments $294.0K $294.0K $275.0K
Other Short-Term Assets $45.00K $1.513M $35.00K
YoY Change 28.57% 0.53% 25.0%
Inventory $442.0K $442.0K $1.167M
Prepaid Expenses $1.097M $873.0K
Receivables $5.167M $5.167M $6.250M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.41M $17.41M $16.82M
YoY Change 3.5% 3.5% 29.51%
LONG-TERM ASSETS
Property, Plant & Equipment $2.798M $5.239M $3.159M
YoY Change -11.43% -0.02% 101.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $490.0K $490.0K $76.00K
YoY Change 544.74% 544.74% -43.28%
Other Assets $805.0K $881.0K $397.0K
YoY Change 102.77% 77.26% 2.32%
Total Long-Term Assets $6.610M $6.610M $5.813M
YoY Change 13.71% 13.71% 164.71%
TOTAL ASSETS
Total Short-Term Assets $17.41M $17.41M $16.82M
Total Long-Term Assets $6.610M $6.610M $5.813M
Total Assets $24.02M $24.02M $22.63M
YoY Change 6.12% 6.12% 49.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.072M $1.072M $2.689M
YoY Change -60.13% -60.13% 218.98%
Accrued Expenses $2.522M $3.452M $2.565M
YoY Change -1.68% -13.48% 15.75%
Deferred Revenue $9.413M $10.68M
YoY Change -11.85% 11.11%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $79.00K $1.104M
YoY Change -100.0% -93.54% 14.05%
Total Short-Term Liabilities $14.02M $14.02M $18.58M
YoY Change -24.56% -23.43% 34.34%
LONG-TERM LIABILITIES
Long-Term Debt $556.0K $582.0K $2.673M
YoY Change -79.2% -78.93% -50.76%
Other Long-Term Liabilities $27.00K $3.277M $144.0K
YoY Change -81.25% 25.51% 0.7%
Total Long-Term Liabilities $583.0K $3.859M $2.817M
YoY Change -79.3% -28.18% -49.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.02M $14.02M $18.58M
Total Long-Term Liabilities $583.0K $3.859M $2.817M
Total Liabilities $17.88M $17.88M $23.68M
YoY Change -24.5% -24.5% 10.47%
SHAREHOLDERS EQUITY
Retained Earnings -$206.4M -$209.5M
YoY Change -1.47% 0.09%
Common Stock $91.00K $80.00K
YoY Change 13.75% 19.4%
Preferred Stock
YoY Change
Treasury Stock (at cost) $169.0K $169.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares $12.72K $12.72K
Shareholders Equity $6.140M $6.140M -$1.048M
YoY Change
Total Liabilities & Shareholders Equity $24.02M $24.02M $22.63M
YoY Change 6.12% 6.12% 49.07%

Cashflow Statement

Concept 2021 Q3 2021 2020 Q3
OPERATING ACTIVITIES
Net Income -$458.0K $3.077M $439.0K
YoY Change -204.33% -1818.99% -345.25%
Depreciation, Depletion And Amortization $497.0K $1.263M $272.0K
YoY Change 82.72% 42.07% -24.23%
Cash From Operating Activities $2.043M $1.246M $2.179M
YoY Change -6.24% -62.71% 25.09%
INVESTING ACTIVITIES
Capital Expenditures -$863.0K $1.482M -$1.053M
YoY Change -18.04% -14.63% 1655.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$863.0K -$1.482M -$1.053M
YoY Change -18.04% -14.63% 1655.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.710M
YoY Change 4982.19%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.431M $2.655M 18.00K
YoY Change 18961.11% 58.98% -102.37%
NET CHANGE
Cash From Operating Activities 2.043M $1.246M 2.179M
Cash From Investing Activities -863.0K -$1.482M -1.053M
Cash From Financing Activities 3.431M $2.655M 18.00K
Net Change In Cash 4.611M $2.370M 1.144M
YoY Change 303.06% -28.7% 24.08%
FREE CASH FLOW
Cash From Operating Activities $2.043M $1.246M $2.179M
Capital Expenditures -$863.0K $1.482M -$1.053M
Free Cash Flow $2.906M -$236.0K $3.232M
YoY Change -10.09% -114.7% 79.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9095355
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
261000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
236000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9064821
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7965325
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9052105
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7952609
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
12716
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
12716
CY2021 sofo Support And Content Hosting Contract Term
SupportAndContentHostingContractTerm
P1Y
CY2021 sofo Standard Product Warranty Term Maximum
StandardProductWarrantyTermMaximum
P1Y
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1614000 USD
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1460000 USD
CY2020 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
0 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 sofo Variable Lease Cost Credit
VariableLeaseCostCredit
-254000 USD
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 USD
CY2021Q3 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 USD
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
CY2020 sofo Additional Discretionary Contributions
AdditionalDiscretionaryContributions
0 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9989000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7619000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5167000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6250000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
442000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
1167000 USD
CY2021Q3 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
294000 USD
CY2020Q3 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
275000 USD
CY2021Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
360000 USD
CY2020Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
440000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1153000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1065000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
17405000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
16816000 USD
CY2021Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1111000 USD
CY2020Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1128000 USD
CY2021Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
8527000 USD
CY2020Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
7960000 USD
CY2021Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1528000 USD
CY2020Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1366000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11166000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10454000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8368000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7295000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2798000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3159000 USD
CY2021Q3 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
490000 USD
CY2020Q3 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
76000 USD
CY2021Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
76000 USD
CY2020Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
100000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2441000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2081000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
805000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
397000 USD
CY2021Q3 us-gaap Assets
Assets
24015000 USD
CY2020Q3 us-gaap Assets
Assets
22629000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1072000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2689000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2522000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2565000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9413000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18580000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10678000 USD
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
79000 USD
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
119000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
930000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1425000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1104000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14016000 USD
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
26000 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
89000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1583000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
665000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
556000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000 USD
CY2021Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
53000 USD
CY2020Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
66000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
144000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
17875000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
23677000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
91000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
80000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
213278000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
209022000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-206442000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-209519000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-618000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-462000 USD
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
169000 USD
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
169000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
6140000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1048000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24015000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22629000 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35167000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34753000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10294000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9634000 USD
CY2021 us-gaap Gross Profit
GrossProfit
24873000 USD
CY2020 us-gaap Gross Profit
GrossProfit
25119000 USD
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11970000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13025000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4870000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5055000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7226000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6303000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
24066000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
24383000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
807000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
736000 USD
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-44000 USD
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-658000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2325000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-109000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2285000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-767000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3092000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
148000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3077000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-179000 USD
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-156000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
84000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-179000 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
49000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
231000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1263000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
889000 USD
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-37000 USD
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
111000 USD
CY2021 sofo Provision For Inventory Reserve
ProvisionForInventoryReserve
-16000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3077000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-179000 USD
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3077000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-179000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8230100
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7216135
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8650384
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7216135
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2921000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-6253000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
158000 USD
CY2020 sofo Stock And Warrants Issued During Period Value New Issues
StockAndWarrantsIssuedDuringPeriodValueNewIssues
137000 USD
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5005000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
84000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-179000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1048000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
487000 USD
CY2021 sofo Stock And Warrants Issued During Period Value New Issues
StockAndWarrantsIssuedDuringPeriodValueNewIssues
3780000 USD
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-156000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3077000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
6140000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3077000 USD
CY2020 sofo Provision For Inventory Reserve
ProvisionForInventoryReserve
122000 USD
CY2021 sofo Gain Loss On Conversion Of Related Party Debt To Equity
GainLossOnConversionOfRelatedPartyDebtToEquity
-0 USD
CY2020 sofo Gain Loss On Conversion Of Related Party Debt To Equity
GainLossOnConversionOfRelatedPartyDebtToEquity
-26000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
487000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
158000 USD
CY2021 sofo Stock Issued For Board Of Directors Fees
StockIssuedForBoardOfDirectorsFees
70000 USD
CY2020 sofo Stock Issued For Board Of Directors Fees
StockIssuedForBoardOfDirectorsFees
63000 USD
CY2021 sofo Deferred Loan Interest To Related Party
DeferredLoanInterestToRelatedParty
0 USD
CY2020 sofo Deferred Loan Interest To Related Party
DeferredLoanInterestToRelatedParty
317000 USD
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
13000 USD
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-57000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2325000 USD
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1015000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7619000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-821000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-268000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-734000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
729000 USD
CY2021 sofo Increase Decrease In Lease Investment
IncreaseDecreaseInLeaseInvestment
452000 USD
CY2020 sofo Increase Decrease In Lease Investment
IncreaseDecreaseInLeaseInvestment
48000 USD
CY2021 sofo Increase Decrease In Capitalized Commissions
IncreaseDecreaseInCapitalizedCommissions
-104000 USD
CY2020 sofo Increase Decrease In Capitalized Commissions
IncreaseDecreaseInCapitalizedCommissions
-30000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
121000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
57000 USD
CY2021 sofo Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-387000 USD
CY2020 sofo Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
492000 USD
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
445000 USD
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-528000 USD
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
438000 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-0 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-989000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1503000 USD
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-110000 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
617000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1246000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3341000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1482000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1736000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1482000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1736000 USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3157000 USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
935000 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1358000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3710000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
73000 USD
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
120000 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
202000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2655000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1670000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-49000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2370000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3324000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7619000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4295000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9989000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
32000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
148000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
97000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
154000 USD
CY2021 sofo Property And Equipment Financed By Finance Lease Or Accounts Payable
PropertyAndEquipmentFinancedByFinanceLeaseOrAccountsPayable
152000 USD
CY2020 sofo Property And Equipment Financed By Finance Lease Or Accounts Payable
PropertyAndEquipmentFinancedByFinanceLeaseOrAccountsPayable
724000 USD
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
5005000 USD
CY2021 sofo Standard Product Warranty Term Minimum
StandardProductWarrantyTermMinimum
P90D
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Concentration of Credit Risk and Other Risks and Uncertainties</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">At <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2021</em>, $6.2 million is deposited with <em style="font: inherit;">one</em> major U.S. financial institution of the $10.0 million total cash and equivalents. At times, deposits in the institution exceed the amount of insurance provided on such deposits. The Company has <em style="font: inherit;">not</em> experienced any losses on such amounts and believes that it is <em style="font: inherit;">not</em> exposed to any significant credit risk on these balances. The remaining $3.8 million of cash and cash equivalents is held by our foreign subsidiaries in financial institutions in Japan and the Netherlands and held in their local currency. The cash held in foreign financial institutions is <em style="font: inherit;">not</em> insured. If the funds held by our foreign subsidiaries were needed for our operations in the United States, the repatriation of some of these funds to the United States could require payment of additional U.S. taxes.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company’s wholly-owned subsidiaries operate in Japan and the Netherlands, and utilize the Japanese Yen and Euro, respectively, as their functional currency. Assets and liabilities of the Company’s foreign operations are translated into US dollars at period end exchange rates while revenues and expenses are translated using average rates for the period. Gains and losses from the translation are deferred and included in accumulated other comprehensive loss on the consolidated statements of comprehensive gain (loss).</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">During fiscal <em style="font: inherit;">2021</em>, the Company recorded an aggregate transaction<span style="background-color:#ffffff;"> gain of $16 </span>thousand compared to an aggregate loss of $36 thousand during fiscal <em style="font: inherit;">2020</em>. The aggregate transaction gain or loss is included in the other expense, net line of the consolidated statements of operations.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We assess the realization of our receivables by performing ongoing credit evaluations of our customers’ financial condition. Through these evaluations, we <em style="font: inherit;"> may </em>become aware of a situation where a customer <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be able to meet its financial obligations due to deterioration of its financial viability, credit ratings or bankruptcy. Our reserve requirements are based on the best information available to us and are reevaluated and adjusted as additional information is received. Our reserves are also based on amounts determined by using percentages applied to certain aged receivable categories. These percentages are determined by a variety of factors including, but <em style="font: inherit;">not</em> limited to, current economic trends, historical payment and bad debt write-off experience. Allowance for doubtful accounts for accounts receivable was $261 thousand at <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2021</em> and $236 thousand at <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2020</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Currently the majority of our product inventory purchases are from <em style="font: inherit;">one</em> <em style="font: inherit;">third</em>-party contract manufacturer. Although we believe there are multiple sources of supply from other contract manufacturers as well as multiple suppliers of component parts required by the contract manufacturers, a disruption of supply of component parts or completed products, even if short term, would have a material negative impact on our revenues. At <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2021</em>, this supplier represented less than 1% of accounts payable while totaling approximately 33% at <em style="font: inherit;"> September 30, 2020. </em>We also license technology from <em style="font: inherit;">third</em> parties that is embedded in our software. We believe there are alternative sources of similar licensed technology from other <em style="font: inherit;">third</em> parties that we could also embed in our software, although it could create potential programming related issues that might require engineering resources.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Use of Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America (US GAAP), management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expense during the period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p>
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10000000.0 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
16000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-36000 USD
CY2021Q3 sofo Accounts And Financing Receivables Allowances
AccountsAndFinancingReceivablesAllowances
261000 USD
CY2020Q3 sofo Accounts And Financing Receivables Allowances
AccountsAndFinancingReceivablesAllowances
236000 USD
CY2021Q3 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
294000 USD
CY2021Q3 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
490000 USD
CY2021Q3 us-gaap Net Investment In Lease
NetInvestmentInLease
784000 USD
CY2021Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
294000 USD
CY2021Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
203000 USD
CY2021Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
203000 USD
CY2021Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
83000 USD
CY2021Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
783000 USD
CY2021Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
0 USD
CY2021Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
783000 USD
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
301000 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
267000 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
247000 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1022000 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
106000 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
122000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
442000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
1167000 USD
CY2021Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
129000 USD
CY2019Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
129000 USD
CY2020 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
2000 USD
CY2020 us-gaap Asset Retirement Obligation Foreign Currency Translation Gain Loss
AssetRetirementObligationForeignCurrencyTranslationGainLoss
-3000 USD
CY2020Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
134000 USD
CY2021 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
2000 USD
CY2021 us-gaap Asset Retirement Obligation Foreign Currency Translation Gain Loss
AssetRetirementObligationForeignCurrencyTranslationGainLoss
7000 USD
CY2021Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
129000 USD
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2006073
CY2021 us-gaap Advertising Expense
AdvertisingExpense
439000 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
395000 USD
CY2021 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
0 USD
CY2020 sofo Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Exercise Factor
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedExerciseFactor
0.012 pure
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8230100
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7216135
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
420284
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8650384
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7216135
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1333174
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1008000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
83000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
862000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
11000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
697000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
9000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
33000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
4000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
3000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
57000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2665000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
110000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
152000 USD
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
5000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2513000 USD
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
105000 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1493000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1383000 USD
CY2020 sofo Variable Lease Cost Credit
VariableLeaseCostCredit
37000 USD
CY2021 us-gaap Lease Cost
LeaseCost
1239000 USD
CY2020 us-gaap Lease Cost
LeaseCost
1420000 USD
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
121000 USD
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
186000 USD
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
10000 USD
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
21000 USD
CY2021 us-gaap Finance Lease Impairment Loss
FinanceLeaseImpairmentLoss
131000 USD
CY2020 us-gaap Finance Lease Impairment Loss
FinanceLeaseImpairmentLoss
207000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1163000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1387000 USD
CY2021 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
10000 USD
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
21000 USD
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
120000 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
202000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y10M24D
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0405 pure
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0911 pure
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0641 pure
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0865 pure
CY2021Q3 us-gaap Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
3155000 USD
CY2021Q3 us-gaap Recorded Unconditional Purchase Obligation Due Within One Year
RecordedUnconditionalPurchaseObligationDueWithinOneYear
245000 USD
CY2021Q3 us-gaap Recorded Unconditional Purchase Obligation Due In Second Year
RecordedUnconditionalPurchaseObligationDueInSecondYear
168000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
556000 USD
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
556000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
556000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1097000 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
873000 USD
CY2021Q3 us-gaap Prepaid Insurance
PrepaidInsurance
11000 USD
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
157000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
45000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
35000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1153000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1065000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1530000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1939000 USD
CY2021Q3 sofo Accrued Expenses Current
AccruedExpensesCurrent
590000 USD
CY2020Q3 sofo Accrued Expenses Current
AccruedExpensesCurrent
289000 USD
CY2021Q3 sofo Interest And Taxes Payable Current
InterestAndTaxesPayableCurrent
241000 USD
CY2020Q3 sofo Interest And Taxes Payable Current
InterestAndTaxesPayableCurrent
316000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
161000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2522000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2565000 USD
CY2021Q3 sofo Number Of Shares Entitled Against Option
NumberOfSharesEntitledAgainstOption
1
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1707515
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.09
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1654429
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.62
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
578467
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.42
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
228750
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.86
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
127555
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.14
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37998
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.53
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
304948
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.89
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
137666
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.82
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1853479
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.44
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1707515
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.09
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1269854
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1367618
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.57
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.84
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2021Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1853479
CY2021Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1269854
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
551000 USD
CY2021Q3 sofo Expected Forfeitures For Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized
ExpectedForfeituresForEmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognized
409000 USD
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
154000 USD
CY2020Q3 sofo Expected Forfeitures For Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized
ExpectedForfeituresForEmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognized
122000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
20000 USD
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
357114
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.77
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
228750
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.84
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
219966
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.12
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
26001
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.54
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
339897
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.60
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
578467
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.57
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
283741
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.98
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
51165
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.09
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
583458
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.43
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
487000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
158000 USD
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
273000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
58000 USD
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 USD
CY2021 sofo Number Of Complete Employment Period On First Day Of Each Offering Period
NumberOfCompleteEmploymentPeriodOnFirstDayOfEachOfferingPeriod
P90D
CY2021 sofo Employee Not Eligible To Participate
EmployeeNotEligibleToParticipate
0.05 pure
CY2021 sofo Eligible Employees Contribution To Purchase Shares
EligibleEmployeesContributionToPurchaseShares
0.10 pure
CY2021 sofo Share Based Compensation Arrangement By Share Based Payment Award Maximum Fair Market Value Of Shares To Be Purchased By Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFairMarketValueOfSharesToBePurchasedByEmployee
25000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
1000
CY2021 sofo Sharebased Compensation Arrangement By Sharebased Payment Award Offering Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOfferingPeriod
P6M
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85 pure
CY2021Q3 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
99673
CY2021 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
9773
CY2020 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
16227
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
945946
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.70
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3500000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
0 USD
CY2020 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
97000 USD
CY2021 sofo Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount
IncomeTaxRateReconciliationPPPLoanForgivenessAmount
-488000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
97000 USD
CY2021 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-5000 USD
CY2020 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
51000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
148000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2702000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-184000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
390000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
153000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3092000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31000 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
649000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-39000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
9000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
148000 USD
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-31000 USD
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0 USD
CY2020 sofo Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount
IncomeTaxRateReconciliationPPPLoanForgivenessAmount
0 USD
CY2021 sofo Income Tax Rate Reconciliation Permanent Difference Net
IncomeTaxRateReconciliationPermanentDifferenceNet
67000 USD
CY2020 sofo Income Tax Rate Reconciliation Permanent Difference Net
IncomeTaxRateReconciliationPermanentDifferenceNet
538000 USD
CY2021 sofo Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount
IncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount
3945000 USD
CY2020 sofo Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount
IncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount
3666000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-4255000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-4298000 USD
CY2021 sofo Income Tax Reconciliation Return To Provision Trueup
IncomeTaxReconciliationReturnToProvisionTrueup
166000 USD
CY2020 sofo Income Tax Reconciliation Return To Provision Trueup
IncomeTaxReconciliationReturnToProvisionTrueup
0 USD
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-47000 USD
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
36000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
148000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9500000 USD
CY2021Q3 sofo Operating Loss Carryforwards Recorded In Apic
OperatingLossCarryforwardsRecordedInApic
1100000 USD
CY2021Q3 sofo Deferred Tax Assets Operating Loss And Other Carry Forward
DeferredTaxAssetsOperatingLossAndOtherCarryForward
16893000 USD
CY2020Q3 sofo Deferred Tax Assets Operating Loss And Other Carry Forward
DeferredTaxAssetsOperatingLossAndOtherCarryForward
20069000 USD
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1003000 USD
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
958000 USD
CY2021Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
343000 USD
CY2020Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
446000 USD
CY2021Q3 sofo Deferred Tax Asset Interest Expense Limitation
DeferredTaxAssetInterestExpenseLimitation
10000 USD
CY2020Q3 sofo Deferred Tax Asset Interest Expense Limitation
DeferredTaxAssetInterestExpenseLimitation
457000 USD
CY2021Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
335000 USD
CY2020Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
433000 USD
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18584000 USD
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22363000 USD
CY2021Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
321000 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
339000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
321000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
339000 USD
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
18263000 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
22024000 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18215000 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21981000 USD
CY2021Q3 sofo Operating Loss Carryforwards Expired
OperatingLossCarryforwardsExpired
18800000 USD
CY2021Q3 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
0 USD
CY2021Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
1600000 USD
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000 USD
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
428000 USD
CY2021 sofo Additional Discretionary Contributions
AdditionalDiscretionaryContributions
0 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35167000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34753000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3500000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4100000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10700000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1600000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1700000 USD
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
10500000 USD
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9900000 USD
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
462000 USD
CY2020 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
491000 USD
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
945946
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.70
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3500000 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35167000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34753000 USD
CY2021Q3 us-gaap Noncurrent Assets
NoncurrentAssets
5585000 USD
CY2020Q3 us-gaap Noncurrent Assets
NoncurrentAssets
6308000 USD

Files In Submission

Name View Source Status
0001437749-21-028230-index-headers.html Edgar Link pending
0001437749-21-028230-index.html Edgar Link pending
0001437749-21-028230.txt Edgar Link pending
0001437749-21-028230-xbrl.zip Edgar Link pending
ex_286060.htm Edgar Link pending
ex_286061.htm Edgar Link pending
ex_286062.htm Edgar Link pending
ex_286063.htm Edgar Link pending
ex_286064.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sofo-20210930.xsd Edgar Link pending
sofo-20210930_cal.xml Edgar Link unprocessable
sofo-20210930_def.xml Edgar Link unprocessable
sofo-20210930_lab.xml Edgar Link unprocessable
sofo-20210930_pre.xml Edgar Link unprocessable
sofo20210930_10k.htm Edgar Link pending
sofo20210930_10k_htm.xml Edgar Link completed